Head of Investor Relations

Reposted 22 Days Ago
Be an Early Applicant
South San Francisco, CA, USA
In-Office
269K-314K Annually
Senior level
Biotech • Pharmaceutical
The Role
The Senior Director of Investor Relations will develop and lead investor relations strategies, engage with analysts and investors, oversee earnings processes, and ensure compliance with disclosure regulations. This role requires extensive experience in investor relations within the pharmaceutical or biotechnology industries.
Summary Generated by Built In

Cytokinetics is a specialty cardiovascular biopharmaceutical company, building on its over 25 years of pioneering scientific innovations in muscle biology, and advancing a pipeline of potential new medicines for patients suffering from diseases of cardiac muscle dysfunction.

The Head of Investor Relations, will serve as a key partner to the SVP of Corporate Affairs and executive leadership team. This individual will lead the strategy and execution of Cytokinetics’ investor relations strategy, ensuring clear, consistent, and compelling communication of our business strategy, financial performance, and long-term value proposition to the investment community. As the company pivots from R&D to a commercial organization, this individual has the opportunity to lead the execution of a comprehensive investor relations program to communicate the company’s commercial progress and success as well as our continued leadership in muscle biology research and development.

This role requires deep pharmaceutical/biotechnology investor relations experience within commercial stage organizations, strong capital markets acumen, executive presence, and the ability to operate seamlessly at both strategic and tactical levels. The ideal candidate is equally comfortable shaping narrative at the Board level and preparing detailed materials for earnings calls and investor conferences.

Key Responsibilities
 

Strategic Leadership

  • Develop and execute a comprehensive investor relations strategy aligned with corporate objectives and key value inflection points.

  • Serve as a trusted advisor to the executive leadership team on investor perception, market dynamics, and capital markets strategy.

  • Closely collaborate with Senior Director, Corporate Communications to shape and refine Cytokinetics’ narrative to ensure clarity, differentiation, and consistency across all investor and other communications.

  • Partner cross-functionally to anticipate and communicate major milestones, including clinical, regulatory, and commercial developments.

Investor & Analyst Engagement

  • Lead engagement with buy-side and sell-side analysts, institutional investors, and key stakeholders. Build and cultivate strong relationships with current and potential new investors

  • Prepare senior leadership for earnings calls, investor conferences, non-deal roadshows, and other investor interactions.

  • Develop and draft briefing materials, Q&A documents, key messaging, and investor presentations.

  • Collaborate with Finance to monitor analyst models, reports, and shareholder base trends; provide actionable insights to executive leadership; engage with analysts to inform consensus.

  • Monitor and alert management to market trends, industry developments, competitor activity and investor sentiment; prepare proactive and reactive plans and statements/messages, including course corrections as needed.

Earnings Preparation

  • Oversee quarterly earnings process, including script preparation, messaging strategy, and coordination across Finance and Corporate Communications.

  • Ensure alignment and accuracy across SEC filings, press releases, investor decks, and website disclosures.

  • Partner with Finance and Legal to ensure compliance with disclosure regulations and best practices.

Qualifications

  • Bachelor’s degree required in Finance, Accounting, Communications; and/or advanced degree preferred.

  • 12+ years of experience in investor relations, equity research, investment banking, or related capital markets roles.

  • Significant investor relations experience within the pharmaceutical or biotechnology industry is required, preferably in a publicly traded, commercial-stage company.

  • Demonstrated experience working closely with C-suite executives and senior stakeholders.

  • Strong understanding of financial and investor markets, accounting principles and regulatory requirements.

  • Strong understanding of drug development, regulatory pathways, clinical data interpretation, and commercial dynamics in biotech/pharma.

  • Exceptional written and verbal communication skills with the ability to translate complex scientific and financial information into compelling narratives.

  • Proven ability to operate strategically while also executing tactically and independently.

  • Results-oriented with proven track record for meeting or exceeding goals

  • Proven ability to maintain confidentiality, exercise judgment and discretion

  • High executive presence, sound judgment, and discretion.

  • Willingness to travel
    #LI-HYBRID

Pay Range:

In the U.S., the hiring pay range for fully qualified candidates is $269,100-$313,950 per year. The base pay actually offered will take into account internal equity and also may vary depending on the candidate's geographic region, job-related knowledge, skills, and experience among other factors.

Our employees come from different backgrounds, and we celebrate those differences. We are looking for the best candidates for our open roles, but do not expect applicants to meet every qualification in order to be considered. If you are excited about what you could accomplish at Cytokinetics and believe you can add value to our team, we would love to hear from you.

Please review our General Data Protection Regulation (GDPR) policy PRIOR to applying.  

Our passion is anchored in robust scientific thinking, grounded in integrity and critical thinking. We keep the patient front and center in all we do – all actions and decisions are in service of the patient and their caregivers. We champion integrity, ethics, doing the right thing, and being our best selves.

Fraud Warning: How to Identify Impersonated Cytokinetics Job Postings and Offers

Recently, there have been fraudulent employment offers being sent to candidates on behalf of Cytokinetics. Please be advised that all legitimate offers from Cytokinetics will come directly from our official email domain (Cytokinetics.com) and will only be made after completing a formal interview process.

Here are some ways to check for authenticity:

  • We do not conduct job interviews through non-standard text messaging applications

  • We will never request personal information such as banking details until after an official offer has been accepted and verified

  • We will never request that you purchase equipment or other items when interviewing or hiring

  • If you are unsure about the authenticity of an offer, or if you receive any suspicious communication, please contact us directly at [email protected]

Please visit our website at: www.cytokinetics.com

Cytokinetics is an Equal Opportunity Employer

Skills Required

  • Bachelor's degree in Finance, Accounting, Communications
  • 12+ years of experience in investor relations or related capital markets roles
  • Significant experience in the pharmaceutical or biotechnology industry
  • Experience working closely with C-suite executives
  • Strong understanding of financial and investor markets, accounting principles, and regulatory requirements
  • Exceptional written and verbal communication skills
  • Proven ability to operate strategically while executing tactically
Am I A Good Fit?
beta
Get Personalized Job Insights.
Our AI-powered fit analysis compares your resume with a job listing so you know if your skills & experience align.

The Company
HQ: South San Francisco, CA
473 Employees
Year Founded: 1998

What We Do

Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. As a leader in muscle biology and the mechanics of muscle performance, we are developing small molecule drug candidates specifically engineered to impact muscle function and contractility. Proud to be a San Francisco Business Times Best Place to Work in 2021 and 2022, a Great Place to Work-Certified company in 2022 and a part of Fortune's Best Workplaces in the Bay Area in 2022 and Fortune's Best Workplaces in BioPharma in 2022.

Similar Jobs

In-Office
San Francisco, CA, USA
66 Employees
243K-310K Annually
In-Office
Mountain View, CA, USA
2359 Employees
277K-351K Annually

Nextdoor Logo Nextdoor

Head of Investor Relations & Corporate Development

Information Technology • Other • Social Media
In-Office
San Francisco, CA, USA
780 Employees
300K-350K Annually

VC Lab Logo VC Lab

Head of Investor Relations (Remote)

Fintech • Financial Services
In-Office or Remote
Palo Alto, CA, USA
146 Employees
100K-150K Annually

Similar Companies Hiring

SOPHiA GENETICS Thumbnail
Software • Healthtech • Biotech • Big Data • Artificial Intelligence
Boston, MA
450 Employees
Pfizer Thumbnail
Artificial Intelligence • Healthtech • Machine Learning • Natural Language Processing • Biotech • Pharmaceutical
New York, NY
121990 Employees
Cencora Thumbnail
Healthtech • Logistics • Pharmaceutical
Conshohocken, PA
51000 Employees

Sign up now Access later

Create Free Account

Please log in or sign up to report this job.

Create Free Account